• Angiotensin II in Abdominal Aortic Aneurysm Models: Protocol

  2026-05-22

  Leverage Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) to model vascular disease, dissect hypertension mechanisms, and drive innovation in cardiovascular remodeling studies. This guide blends evidence-backed protocols, troubleshooting, and the latest molecular insights for reproducible, high-impact vascular research.

• Tivozanib (AV-951): Next-Gen VEGFR Inhibition in Oncology Re

  2026-05-21

  Discover how Tivozanib (AV-951) advances anti-angiogenic therapy with unmatched selectivity and potency in the VEGFR signaling pathway. This article explores unique protocol insights and practical considerations for maximizing research impact.

• Lamotrigine in Epilepsy and Cardiac Sodium Channel Research

  2026-05-21

  Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) is a high-purity sodium channel blocker and 5-HT inhibitor pivotal for reproducible epilepsy and cardiac arrhythmia assays. Discover how APExBIO’s formulation empowers advanced experimental workflows and troubleshooting in sodium channel and serotonin pathway modulation.

• BRD4 Inhibition Enhances Erastin-Induced Ferroptosis via ROS

  2026-05-20

  This study demonstrates that BET inhibitors, including I-BET-762, broadly sensitize diverse cell lines to erastin-induced ferroptosis by promoting ROS accumulation and FSP1 downregulation. The findings clarify the mechanistic interplay between epigenetic regulation and ferroptosis, suggesting new combinatorial strategies for cancer research.

• Aztreonam: Monocyclic β-Lactam Antibiotic in Resistance Rese

  2026-05-20

  Aztreonam’s unique monocyclic β-lactam structure and robust solubility profile position it as a premier tool for Gram-negative resistance studies and experimental modeling of drug metabolism. This guide details practical workflows, protocol optimization, and troubleshooting strategies to maximize research outcomes with Aztreonam from APExBIO.

• Sodium Overload Disrupts Mitochondrial Metabolism in NECSO

  2026-05-19

  Qiao et al. (2025) reveal how pathological sodium influx, mediated by TRPM4 activation, impairs mitochondrial energy metabolism, triggering necrosis via NECSO. Their mechanistic insights provide new directions for mitochondrial bioenergetics research and cell death studies.

• CX-4945 (Silmitasertib): CK2 Inhibition Beyond Oncology

  2026-05-19

  Explore CX-4945 (Silmitasertib) as a potent CK2 inhibitor in cancer and viral research. This in-depth analysis unveils mechanistic insights and practical strategies, highlighting a unique cross-domain application supported by recent breakthroughs.

• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-05-18

  This study reveals that phenothiazines, including Perphenazine, enhance the antibacterial functions of macrophages by inducing reactive oxygen species (ROS) accumulation and autophagy. These findings advance host-directed therapy strategies for combating intracellular bacterial infections, offering a promising pathway beyond conventional antibiotics.

• Programming CAR Macrophages via mRNA-LNP for Peritoneal Tumo

  2026-05-18

  This study presents a macrophage-targeted mRNA lipid nanoparticle (mRNA-LNP) system for in situ programming of chimeric antigen receptor macrophages (CAR-Ms) to treat peritoneal metastasis in solid tumors. The work systematically compares 36 CAR formats, revealing that specific CAR-Ms synergize with checkpoint blockade therapy and remodel the tumor microenvironment, offering new directions for solid tumor immunotherapy.

• BH4 Oxidation Drives B-Raf–ERK1/2 Activation in DRG Neurons

  2026-05-17

  This study reveals that hydrogen peroxide (H2O2), a by-product of tetrahydrobiopterin (BH4) oxidation, specifically activates the B-Raf–MEK1/2–ERK1/2 pathway in rat dorsal root ganglion (DRG) neurons, driving pain hypersensitivity. These findings highlight a novel downstream target for modulating pain sensitization without altering systemic BH4 levels.

• Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays in Canc

  2026-05-16

  Ferrostatin-1 (Fer-1) empowers researchers to dissect ferroptosis with nanomolar precision, unlocking new experimental depth in cancer and neurodegeneration models. This article details advanced workflows, troubleshooting strategies, and actionable protocol enhancements for robust oxidative lipid damage inhibition.

• DAPT (GSI-IX): Unraveling Notch Pathway Roles in Human Senso

  2026-05-15

  Explore how DAPT (GSI-IX) drives innovation in Notch signaling pathway research, with new insights into human sensory neuron models and latent viral infection. This article offers a deep scientific analysis distinct from existing content.

• Quercetin Mitigates Cataract via Hippo Pathway Modulation: N

  2026-05-15

  This study provides mechanistic evidence that quercetin alleviates cataract pathology by modulating the Hippo signaling pathway, promoting lens epithelial cell survival and reducing oxidative stress. The findings highlight the therapeutic potential of Hippo pathway modulation in cataract prevention, with implications for future pharmacological strategies.

• KU-60019: ATM Kinase Inhibitor for Radiosensitizing Glioma

  2026-05-14

  KU-60019 stands out as a highly selective ATM kinase inhibitor, enabling precise radiosensitization and inhibition of glioma cell migration and invasion. This article dissects experimental workflows, troubleshooting tips, and unique insights from recent research to maximize the utility of KU-60019 in advanced DNA damage response studies.

• Helper-Polymer FNPs Enable Stable Lung-Specific mRNA Deliver

  2026-05-14

  This study introduces five-element nanoparticles (FNPs) incorporating poly(β-amino esters) and DOTAP, achieving efficient, lung-targeted mRNA delivery with remarkable stability after lyophilization. The findings represent a significant advance for mRNA-based therapies by addressing longstanding storage and delivery challenges.

15613 records 2/1041 page Previous Next 12345 下5页 Last page